Serum Neurofilament Light and Multiple Sclerosis Progression Independent of Acute Inflammation.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 35133438.
- Also identified by DOI 10.1001/jamanetworkopen.2021.47588 and PMC identifier 8826177.
- Licence recorded as CC BY-NC-ND.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This cohort study investigates serum neurofilament light concentration as a biomarker associated with disability progression in multiple sclerosis in the absence of acute inflammation.
Medical subject headings
- Biomarkers
- Multiple Sclerosis
- Neurofilament Proteins